Mexico Cancer Diagnostics Market Size & Outlook, 2023-2030
Mexico cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Mexico cancer diagnostics market highlights
- The Mexico cancer diagnostics market generated a revenue of USD 2,011.1 million in 2023 and is expected to reach USD 3,107.1 million by 2030.
- The Mexico market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 2,011.1 million |
| Market revenue in 2030 | USD 3,107.1 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.9% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 3,107.1 million by 2030.
Consumables was the largest segment with a revenue share of 59.97% in 2023. Horizon Databook has segmented the Mexico cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
In Mexico, mortality and incidence of breast cancer have increased in the past few years. Changes in healthcare policies in the country include various programs for access to early diagnosis and treatment in case of breast cancer. High breast cancer incidence in the country is leading to increase in the usage of various novel early cancer detection techniques.
Breast cancer accounted for 7,931 deaths in 2020, followed by prostate cancer, which caused around 7,457 deaths in the same year. Furthermore, Mexico's cancer diagnostics market is growing at a high rate due to increasing collaborations between key market players.
For instance, in January 2017, Cynvenio Biosystems, Inc. entered into a distribution agreement with Milenia Labs for Cynvenio’s ClearID Breast Cancer. This agreement enabled the availability of ClearID Breast Cancer for customers through Milenia Labs and its network of 12 diagnostic centers in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico cancer diagnostics market size, by product, 2018-2030 (US$M)
Mexico Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
